If the industry can figure out 3D printing’s regulatory hurdles, we may be on the cusp of a revolution: the democratization of personalized precision.

AI opens up new opportunities in R&D – and also provides pharma companies with new ways to connect with patients for better outcomes.

We speak with G-CON’s Maik Jornitz about his career and desire to give back by training the next generation.

Could frozen microneedles change the way we deliver cell therapies?

Sitting Down With… Sudarshan Jain, Secretary-General of the Indian Pharmaceutical Alliance.

Watch our video interview with Maik Jornitz.

Implementing sustainable practices for a better future.

A report suggests that more needs to be done to combat bleeding disorders. Is pharma playing its part in addressing this issue?

There are myriad opportunities to use digital tech to improve lab efficiency.

Mighty mRNA molecules have won the COVID-19 vaccine race, but there is room for improvement.